Evidence map›Paper›PMID 35448647›Full record

ReviewVeterinary sciences2022

Clinical Guidelines for the Use of Antipruritic Drugs in the Control of the Most Frequent Pruritic Skin Diseases in Dogs.

Vincent Bruet, Marion Mosca, Amaury Briand, Patrick Bourdeau, Didier Pin, Noëlle Cochet-Faivre, Marie-Christine Cadiergues

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Anti-Cytokine Drugs in the Treatment of Canine Atopic Dermatitis.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Vincent BruetVeterinary Dermatology Referral Services, 44100 Nantes, France.
Marion MoscaUniversité de Lyon, VetAgro Sup, Interactions Cells Environment, UPSP 2016.A104, 69280 Marcy l'Etoile, France.
Amaury BriandDepartment of Dermatology, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons-Alfort, France.ORCID 0000-0002-3440-1270
Patrick BourdeauDepartment of Clinical Sciences, ENVN (Oniris) Université de Nantes, 44307 Nantes, France.
Didier PinUniversité de Lyon, VetAgro Sup, Interactions Cells Environment, UPSP 2016.A104, 69280 Marcy l'Etoile, France.ORCID 0000-0001-7424-0013
Noëlle Cochet-FaivreDepartment of Dermatology, Ecole Nationale Vétérinaire d'Alfort, 94700 Maisons-Alfort, France.
Marie-Christine CadierguesDepartment of Clinical Sciences, Université de Toulouse, ENVT, 31076 Toulouse, France.ORCID 0000-0001-6909-0153
École Nationale Vétérinaire d'Alfort · FRUniversité Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FROniris · FR

Funding

Zoetis (France) no number
6 · The paper itself

Abstract

Pruritus is a common clinical sign in many skin disorders and is currently the main complaint in canine dermatology. Pruritic skin diseases can affect the quality of life of dogs and their owners. Several families of antipruritic drugs are available to help control pruritus in dogs. The aim of this review is to help practitioners select the most appropriate symptomatic treatment in the most frequent situations of dermatological pruritus in dogs. The molecules reviewed here are systemic and topical glucocorticoids, antihistamines, ciclosporin, oclacitinib and lokivetmab. A level of evidence (1, 2 or 3) has been established according to a detailed algorithm for each individual study in the literature published between 1990 and March 2021. The guidelines result from evidence grading using the strength of recommendation taxonomy (SoRT) and clinical recommendations using a thorough methodology.

Indexed as

allergyantihistaminesatopic dermatitisciclosporindogglucocorticoidslokivetmaboclacitinibpruritus

Identifiers

PMID35448647
PMCPMC9030482
OpenAlexW4220918749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.